UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) – Equities research analysts at SVB Leerink decreased their Q2 2022 earnings per share (EPS) estimates for UnitedHealth Group in a research report issued to clients and investors on Monday, April 18th. SVB Leerink analyst W. Mayo now forecasts that the healthcare conglomerate will earn $5.16 per share for the quarter, down from their prior forecast of $5.30. SVB Leerink currently has a “Outperform” rating and a $600.00 target price on the stock. SVB Leerink also issued estimates for UnitedHealth Group’s FY2022 earnings at $21.68 EPS, Q1 2023 earnings at $6.36 EPS, Q2 2023 earnings at $5.94 EPS, FY2023 earnings at $24.99 EPS, FY2024 earnings at $28.63 EPS and FY2025 earnings at $32.96 EPS.
A number of other analysts also recently weighed in on the stock. Cowen increased their price target on shares of UnitedHealth Group from $512.00 to $596.00 in a report on Monday. Sanford C. Bernstein increased their price target on shares of UnitedHealth Group from $508.00 to $564.00 in a report on Tuesday, January 11th. BMO Capital Markets increased their price target on shares of UnitedHealth Group from $510.00 to $600.00 and gave the company a “market perform” rating in a report on Tuesday. Raymond James increased their price target on shares of UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a report on Tuesday. Finally, Royal Bank of Canada set a $563.00 price objective on shares of UnitedHealth Group and gave the stock an “outperform” rating in a report on Monday. Two investment analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $542.13.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.38 by $0.11. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The business had revenue of $80.15 billion for the quarter, compared to analyst estimates of $78.77 billion. During the same period last year, the business posted $5.31 EPS. UnitedHealth Group’s revenue was up 14.2% compared to the same quarter last year.
Institutional investors and hedge funds have recently made changes to their positions in the business. Outfitter Financial LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Blue Bell Private Wealth Management LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $29,000. Advocacy Wealth Management Services LLC lifted its position in shares of UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. lifted its position in shares of UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 30 shares in the last quarter. Finally, Tortoise Investment Management LLC lifted its position in shares of UnitedHealth Group by 54.8% in the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 23 shares in the last quarter. 86.07% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, January 20th. The shares were sold at an average price of $469.41, for a total transaction of $2,347,050.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Paul R. Garcia acquired 2,146 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, February 22nd. The shares were purchased at an average cost of $464.97 per share, for a total transaction of $997,825.62. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 23,000 shares of company stock valued at $11,123,890. 0.55% of the stock is owned by corporate insiders.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 22nd. Stockholders of record on Monday, March 14th were given a dividend of $1.45 per share. This represents a $5.80 annualized dividend and a dividend yield of 1.08%. The ex-dividend date was Friday, March 11th. UnitedHealth Group’s dividend payout ratio is 31.75%.
UnitedHealth Group Company Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- 3 Analyst Favorite Blue-Chip Stocks to Buy Now
- Does PNC Financial Stock Belong in Your Portfolio?
- Institutional Buying Puts A Bottom In Manpower Group Inc
- Workhorse Johnson & Johnson Plows New All-Time Highs
- Fastenal Stock is Ready to Sprint Higher
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.